ChemoMetec

ISIN DK0060055861

 | 

WKN A0MS80

Marktkapitalisatie (in EUR)
1,079 m
Land
Denmark
Sector
Healthcare
Dividendrendement
1.51%
 

Overview

Description

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for fluid cell count and analysis. It operates through the following segments: Instruments, Consumer Goods, Service, and Others. The Instruments segment sells NucleoCounter NC-100, NC-200, NC250, and NC-3000. The Consumer Goods segment offers disposable cartridges, disposable analysis chambers, reagents, and test kits. The Service segment provides service packages and its corresponding guarantees. The Others segment offers measuring modules and accessories. The company was founded by Hans Martin Glensbjerg in 1997 and is headquartered in Allerod, Denmark.
Show more Show less
Healthcare Healthcare Services Miscellaneous Healthcare Denmark

Financials

Key metrics

Market capitalisation, EUR 1,079 m
EPS, EUR -
P/B ratio 12.4
P/E ratio 45.5
Dividend yield 1.51%

Income statement (2025)

Revenue, EUR 66 m
Net income, EUR 25 m
Profit margin 37.61%

What ETF is ChemoMetec in?

There are 2 ETFs which contain ChemoMetec. All of these ETFs are listed in the table below. The ETF with the largest weighting of ChemoMetec is the Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing.
ETF Weight Investment focus Fund size (in m EUR)
Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing 0.02%
Equity
Europe
Social/Environmental
33
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
489
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.